Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2011
- Grundlagt
Nøglebeslutningstagere
Magnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556866422001
Beslutningstagere
6 kontakter i FunnelfeedrMagnus Hurst
CFO & acting CEO
Antonio Bermejo Gómez
Chief Development Officer
Mats Persson
Board Member
Maria Nyhage
Board Member
Fredrik Lehmann
Founder & Chairman
Andre kontakter
Dr. Ali Mobasheri
Scientific Advisor
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrStayble Therapeutics AB
5–9 medarbejdereDeveloping an injection treatment for pain caused by disc herniation.
Pharmnovo Aktiebolag
1–4 medarbejdereDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Xintela AB
10–19 medarbejdereDeveloping stem cell and targeted cancer therapies for unmet needs.
REGENARTI AS
Norwegian company developing peptide-enhanced gel for joint repair.
SynAct Pharma AB
5–9 medarbejdereClinical-stage biotech resolving inflammation via novel oral therapies.
Udforsk mere
Spørgsmål om Synartro AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo